Radiofrequency ablation for thyroid nodules and low-risk cancer
Part of Cancer, Hormones & metabolism clinical trials.
This trial tests radiofrequency ablation (a heat-based treatment) for people with non-cancerous or suspicious thyroid nodules, or small thyroid cancers. It may be an option if you are not a candidate for or choose not to have surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and cannot have or do not want surgery.
- You have a thyroid nodule proven to be benign (non-cancerous) that causes symptoms like pressure or trouble swallowing, or you have a nodule that looks suspicious but not clearly cancerous, or a small thyroid cancer that has not spread, or a small recurrence of thyroid cancer.
- You are scheduled to have an ultrasound-guided radiofrequency ablation for your thyroid condition.
- You are willing and able to give written permission to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is studying a treatment called thermal ablation (using heat to destroy cancer cells) for people with small, low-risk papillary thyroid cancer. It aims to see how well it works and to predict outcomes.
This trial tests a minimally invasive heat treatment (thermal ablation) guided by ultrasound for small papillary thyroid cancers. It may be an option for patients who want to avoid surgery.
This trial tests a new procedure called nanosecond pulsed field ablation (nsPFA) to shrink benign thyroid nodules that are causing symptoms like tightness in the throat or trouble swallowing.
This trial tests a procedure called radiofrequency ablation to treat small, low-risk thyroid cancer. If you have a small nodule (2 cm or less) that is confirmed as cancer or suspicious for cancer (Bethesda 5/6), this treatment may be an option instead of surgery.
This study tests whether radiofrequency ablation (a heat-based treatment applied through the skin) can safely and effectively cure small, low-risk papillary thyroid cancers. It is designed for people whose tumors are small, have not spread, and who either cannot have surgery or prefer not to.
This trial studies radiofrequency ablation, a procedure that shrinks a thyroid nodule, for thyroid nodules that are unclear on biopsy but have a reassuring “molecular” test. If you have a Bethesda III nodule that tests benign on specific genetic tests, you may be a good candidate to see if this approach helps safely.
Hear when a new Low Risk trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.